Company Update (NYSE:LLY): Lilly to test combinations with Merck, Bristol-Myers’ cancer drugs

[Reuters] – Eli Lilly & Co signed two separate deals with Merck & Co Inc and Bristol-Myers Squibb Co to test combinations of its cancer treatments with two recently approved therapies that belong . . . → Read More: Company Update (NYSE:LLY): Lilly to test combinations with Merck, Bristol-Myers’ cancer drugs Similar Articles: Stock Update (NYSE:PFE): AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer Company Update (NYSE:LLY): Lilly Declares Fourth-Quarter 2014 Dividend Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly to Participate in Morgan Stanley 2014 Global Healthcare Conference